11:00 AM

Gamma Knife Icon offers powerful, precise treatment for even the most serious brain conditions

Learn more about the malignant and benign conditions it treats.

Gamma Knife® Icon™ was specifically designed by neurosurgeons to treat patients with several kinds of malignant and benign conditions that affect the head and brain. As the “gold standard” for radiosurgery treatment, this non-invasive device is able to aim 192 tiny beams of precisely focused radiation into even the most delicate and hard-to-reach areas of the brain without harming surrounding healthy tissue.

What this means is more ‘inoperable’ and hard-to-treat brain conditions are now treatable, giving patients real hope and relief from debilitating symptoms.

“Even patients with the most serious brain conditions (listed below) are candidates for Gamma Knife treatment,” says Alyson McIntosh, MD, a radiation oncologist with Allentown Radiation Oncology Associates at Lehigh Valley Hospital–Cedar Crest and medical director of the Gamma Knife program at LVHN. ”Our radiosurgery team is highly skilled in using this powerful technology to effectively target and shrink many types of brain tumors and relieve symptoms from other neurological disorders. Not only is Gamma Knife a relatively quick outpatient procedure that lets you go home the same day, but it’s also the most accurate and effective stereotactic brain treatment available.”

Here are conditions that Gamma Knife Icon treats:

  • Brain metastases
  • Meningiomas
  • Pituitary adenomas
  • Acoustic neuromas
  • Trigeminal neuralgia
  • Arteriovenous malformations (AVMs)
  • Recurrent gliomas

If you suffer from one of these brain disorders, be sure to talk to your doctor about this painless alternative to traditional brain surgery. Depending on your condition and the length of your procedure, you may also qualify to use the Gamma Knife Icon’s frameless treatment option that provides improved patient comfort.

Learn more about Gamma Knife in our informational guide > Download Gamma Knife guide.